STOCK TITAN

Alpha Cognition (ACOG) VP granted RSUs and stock options on new awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Alpha Cognition Inc. officer Henry Huy Du, VP Finance and Accounting, reported equity awards dated January 9, 2026. He acquired 20,579 common shares at a price of $0, reported as restricted stock units that vest one‑third on January 9, 2027, one‑third on January 9, 2028, and one‑third on January 9, 2029. He also received 15,982 common share options with an exercise price of $6.56 per share, vesting one‑third on January 9, 2027 and the remainder in equal quarterly installments, and expiring on January 9, 2036. After these grants, he beneficially owns 20,579 common shares and 15,982 options, all held directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DU HENRY HUY

(Last) (First) (Middle)
C/O ALPHA COGNITION INC.
1200 - 750 WEST PENDER STREET

(Street)
VANCOUVER A1 V6C 2T8

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alpha Cognition Inc. [ ACOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP Finance and Accounting
3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 01/09/2026 A 20,579(1) A $0 20,579 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Share Options $6.56 01/09/2026 A 15,982 (2) 01/09/2036 Common Shares 15,982 $0 15,982 D
Explanation of Responses:
1. Restricted stock units that vest on 1/3 on January 9, 2027, 1/3 on January 9, 2028 and 1/3 on January 9, 2029.
2. The options will vest 1/3 on January 9, 2027 and the remainder to vest in equal installments quarterly thereafter.
Henry Huy Du 01/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Alpha Cognition (ACOG) report for Henry Huy Du?

Henry Huy Du, VP Finance and Accounting, reported awards of 20,579 common shares and 15,982 common share options granted on January 9, 2026.

Were the Alpha Cognition (ACOG) shares in this Form 4 a purchase or a grant?

The 20,579 common shares were acquired at a price of $0, indicating an equity award rather than an open-market purchase.

What are the vesting terms of Henry Huy Dus restricted stock units at Alpha Cognition (ACOG)?

The restricted stock units covering 20,579 shares vest in three equal parts on January 9, 2027, January 9, 2028, and January 9, 2029.

What are the key terms of the stock options reported by Alpha Cognition (ACOG)?

The 15,982 common share options have an exercise price of $6.56, start vesting on January 9, 2027, with the remainder vesting quarterly, and expire on January 9, 2036.

How many Alpha Cognition (ACOG) securities does Henry Huy Du hold after this Form 4?

Following these transactions, he beneficially owns 20,579 common shares and 15,982 common share options, all reported as held directly.

What is Henry Huy Dus role at Alpha Cognition (ACOG) according to this filing?

He is reported as an officer of Alpha Cognition Inc., serving as VP Finance and Accounting.

Alpha Cognition

NASDAQ:ACOG

ACOG Rankings

ACOG Latest News

ACOG Latest SEC Filings

ACOG Stock Data

126.54M
19.65M
12.97%
35.39%
0.5%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Canada
VANCOUVER